{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:10:00Z","timestamp":1789085400129,"version":"build-2803163510"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Eve Appeal","award":["EVE0042"],"award-info":[{"award-number":["EVE0042"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Uterine sarcomas can be difficult to differentiate from uterine fibroids due to many shared symptoms and imaging features, which can result in delayed or missed diagnosis, or over treatment. The \u2018Development of a blood test for uterine Sarcoma \u2013 Diagnosis\u2019 (DOORS-D) (ISRCTN14800787) and \u2018Development of a blood test for uterine Sarcoma \u2013 Monitoring\u2019 (DOORS-M) (ISRCTN14174468) studies aim to explore the role for circulating tumour DNA (ctDNA) to diagnose and to monitor uterine sarcomas. DOORS-D will recruit patients who have a suspected uterine sarcoma or large fibroid and are due to undergo surgery (hysterectomy or myomectomy) for a blood sample prior to surgery whereas DOORS-M will recruit patients who have been diagnosed with a uterine sarcoma in the previous 10 years for longitudinal blood sampling every 3\u20136 months over the course of the study. Information will be collated on patient characteristics and symptoms, tumour characteristics and diagnostic imaging, with representative images selected and analysed using large language models. Analysis of genomic\/methylation profile of ctDNA samples collected from DOORS-M will be used to design a ctDNA-based \u2018test\u2019. Analysis of the samples collected from the participants recruited to the DOORS-D study will enable the accuracy of the \u2018test\u2019 to differentiate uterine sarcomas from fibroids to be determined. In addition, the opinions of patients with a suspected or confirmed sarcoma will be explored through semi-structured qualitative interviews. Purposeful recruitment strategy will ensure that the experiences of women from diverse socioeconomic, cultural and ethnic backgrounds are included. The results of the studies will be shared through conference presentations and peer-reviewed publications.<\/jats:p>","DOI":"10.1371\/journal.pone.0339336","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T18:43:51Z","timestamp":1771353831000},"page":"e0339336","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of a blood test for uterine sarcoma\u2014Diagnosis and monitoring (DOORS-D and DOORS-M) studies"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4692-4869","authenticated-orcid":true,"given":"Anna","family":"Casey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Allsopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqui","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Cowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Stannard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indrajeet","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Wadsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Darko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2650-0172","authenticated-orcid":true,"given":"Esther L.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"issue":"12","key":"pone.0339336.ref001","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S1470-2045(09)70226-8","article-title":"Clinical management of uterine sarcomas","volume":"10","author":"F Amant","year":"2009","journal-title":"Lancet Oncol"},{"issue":"9","key":"pone.0339336.ref002","doi-asserted-by":"crossref","first-page":"101992","DOI":"10.1016\/j.ijgc.2025.101992","article-title":"Uterine leiomyosarcoma","volume":"35","author":"G Bogani","year":"2025","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"pone.0339336.ref003","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jmig.2016.01.022","article-title":"The Role of Endometrial Biopsy in the Preoperative Detection of Uterine Leiomyosarcoma","volume":"23","author":"EM Hinchcliff","year":"2016","journal-title":"J Minim Invasive Gynecol"},{"key":"pone.0339336.ref004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2017.09.004","article-title":"Epidemiology and Risk Factors of Uterine Fibroids","volume":"46","author":"D Pavone","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"pone.0339336.ref005","doi-asserted-by":"crossref","first-page":"101631","DOI":"10.1016\/j.jogoh.2019.101631","article-title":"Incidence and outcome of occult uterine sarcoma: A multi-centre study of 18604 operations performed for presumed uterine leiomyoma","volume":"49","author":"A Yorganc\u0131","year":"2020","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"2","key":"pone.0339336.ref006","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/01.EDE.0000054360.61254.27","article-title":"Why is parity protective for uterine fibroids?","volume":"14","author":"DD Baird","year":"2003","journal-title":"Epidemiology"},{"issue":"6","key":"pone.0339336.ref007","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0029-7844(97)00534-6","article-title":"Variation in the incidence of uterine leiomyoma among premenopausal women by age and race","volume":"90","author":"LM Marshall","year":"1997","journal-title":"Obstet Gynecol"},{"key":"pone.0339336.ref008","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmig.2015.08.250","article-title":"A Multi-Center Retrospective Review of Clinical Characteristics of Uterine Sarcoma","volume":"22","author":"M Wais","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"issue":"9","key":"pone.0339336.ref009","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/PAS.0000000000001746","article-title":"Intraoperative Frozen Section Biopsy of Uterine Smooth Muscle Tumors: A Clinicopathologic Analysis of 112 Cases With Emphasis on Potential Diagnostic Pitfalls","volume":"45","author":"J Lok","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"pone.0339336.ref010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamcollsurg.2021.07.321","article-title":"Accuracy of Frozen Section Analysis in the Intraoperative Diagnosis of Uterine Leiomyosarcoma: Experience at a Large Metropolitan Hospital","volume":"233","author":"JA Hagen","year":"2021","journal-title":"Journal of the American College of Surgeons"},{"issue":"2","key":"pone.0339336.ref011","article-title":"A Retrospective Analysis of the Impact of Myomectomy on Survival in Uterine Sarcoma","volume":"11","author":"Z Gao","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"pone.0339336.ref012","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jmig.2014.04.010","article-title":"In-bag morcellation","volume":"21","author":"JI Einarsson","year":"2014","journal-title":"J Minim Invasive Gynecol"},{"key":"pone.0339336.ref013","unstructured":"US Food and Drug Administration 2023. Accessed 09.02.2026 https:\/\/www.fda.gov\/medical-devices\/surgery-devices\/laparoscopic-power-morcellators"},{"issue":"4","key":"pone.0339336.ref014","first-page":"412","article-title":"Assessment of the predictivity of preoperative serum CA 125 in the differential diagnosis of uterine leiomyoma and uterine sarcoma in the Turkish female population","volume":"30","author":"N Yilmaz","year":"2009","journal-title":"Eur J Gynaecol Oncol"},{"issue":"4","key":"pone.0339336.ref015","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/ijgc-00009577-200207000-00005","article-title":"Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus","volume":"12","author":"A Goto","year":"2002","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"pone.0339336.ref016","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.fertnstert.2020.07.020","article-title":"Specificity of the lactate dehydrogenase isoenzyme index as a preoperative screen for uterine sarcoma before myomectomy","volume":"115","author":"LE Spivack","year":"2021","journal-title":"Fertil Steril"},{"key":"pone.0339336.ref017","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.2147\/CMAR.S314219","article-title":"Preoperative Blood Inflammatory Markers for the Differentiation of Uterine Leiomyosarcoma from Leiomyoma","volume":"13","author":"DS Suh","year":"2021","journal-title":"Cancer Manag Res"},{"issue":"1","key":"pone.0339336.ref018","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijgo.15136","article-title":"Diagnostic accuracy of MRI in the differential diagnosis between uterine leiomyomas and sarcomas: A systematic review and meta-analysis","volume":"165","author":"A Raffone","year":"2024","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"pone.0339336.ref019","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.211658","article-title":"MRI Evaluation of Uterine Masses for Risk of Leiomyosarcoma: A Consensus Statement","volume":"306","author":"N Hindman","year":"2023","journal-title":"Radiology"},{"key":"pone.0339336.ref020","doi-asserted-by":"crossref","first-page":"20363613251327080","DOI":"10.1177\/20363613251327080","article-title":"Comparison of MRI imaging features to differentiate degenerating fibroids from uterine leiomyosarcomas","volume":"17","author":"WW Loughborough","year":"2025","journal-title":"Rare Tumors"},{"issue":"4","key":"pone.0339336.ref021","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.tjog.2017.05.003","article-title":"Efficacy of PET\/CT to exclude leiomyoma in patients with lesions suspicious for uterine sarcoma on MRI","volume":"56","author":"S Kusunoki","year":"2017","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"14","key":"pone.0339336.ref022","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1158\/1078-0432.CCR-19-3959","article-title":"Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing","volume":"26","author":"ML Hensley","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"1","key":"pone.0339336.ref023","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1038\/s41467-025-57483-5","article-title":"Genome-wide meta-analysis identifies novel risk loci for uterine fibroids within and across multiple ancestry groups","volume":"16","author":"J Kim","year":"2025","journal-title":"Nat Commun"},{"key":"pone.0339336.ref024","article-title":"Detection of Circulating Tumor DNA in Patients With Uterine Leiomyomas","volume":"3","author":"J Przybyl","year":"2019","journal-title":"JCO Precis Oncol"},{"issue":"12","key":"pone.0339336.ref025","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.medj.2021.11.001","article-title":"Liquid biopsies for residual disease and recurrence","volume":"2","author":"JCM Wan","year":"2021","journal-title":"Med"},{"issue":"8","key":"pone.0339336.ref026","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.3390\/cancers12082231","article-title":"Utility of Circulating Tumor DNA for Detection and Monitoring of Endometrial Cancer Recurrence and Progression","volume":"12","author":"EL Moss","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"24","key":"pone.0339336.ref027","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1158\/1078-0432.CCR-24-2105","article-title":"Genomic Landscape of ctDNA and Real-World Outcomes in Advanced Endometrial Cancer","volume":"30","author":"P Soberanis Pina","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"1","key":"pone.0339336.ref028","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2025.36.e5","article-title":"Selective utilization of circulating tumor DNA testing enables disease monitoring in endometrial and ovarian carcinomas","volume":"36","author":"A Jamieson","year":"2025","journal-title":"J Gynecol Oncol"},{"key":"pone.0339336.ref029","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ygyno.2023.12.025","article-title":"Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies","volume":"182","author":"F Recio","year":"2024","journal-title":"Gynecol Oncol"},{"key":"pone.0339336.ref030","doi-asserted-by":"crossref","unstructured":"Chitrakar A, Ashmore A, Bujkiewicz S, Wheaton L, Pepper C, Guttery DS, et al. Blood-based biomarkers to diagnose and monitor recurrent endometrial cancer: A systematic review and meta-analysis. 2025. doi: 10.1101\/2025.08.28.25333862","DOI":"10.1101\/2025.08.28.25333862"},{"issue":"1","key":"pone.0339336.ref031","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/cancers15010157","article-title":"Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma","volume":"15","author":"M Zhou","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"pone.0339336.ref032","doi-asserted-by":"crossref","first-page":"64","DOI":"10.36401\/JIPO-20-3","article-title":"Identification of Genetic Alterations by Circulating Tumor DNA in Leiomyosarcoma: A Molecular Analysis of 73 Patients","volume":"3","author":"J Arshad","year":"2020","journal-title":"J Immunother Precis Oncol"},{"issue":"1","key":"pone.0339336.ref033","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12967-020-02493-8","article-title":"Low molecular weight serum cell-free DNA concentration is associated with clinicopathologic indices of poor prognosis in women with uterine cancer","volume":"18","author":"GM Gressel","year":"2020","journal-title":"J Transl Med"},{"issue":"12","key":"pone.0339336.ref034","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1111\/cas.14215","article-title":"Serum microRNA profile enables preoperative diagnosis of uterine leiomyosarcoma","volume":"110","author":"A Yokoi","year":"2019","journal-title":"Cancer Sci"},{"issue":"4","key":"pone.0339336.ref035","article-title":"Patient acceptability of circulating tumour DNA testing in endometrial cancer follow-up","volume":"30","author":"A Relton","year":"2021","journal-title":"Eur J Cancer Care (Engl)"},{"key":"pone.0339336.ref036","article-title":"SPIRIT 2025 statement: updated guideline for protocols of randomised trials","volume":"389","author":"A-W Chan","year":"2025","journal-title":"BMJ"},{"key":"pone.0339336.ref037","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-69909-7_3470-2","volume-title":"Thematic analysis","author":"V Braun","year":"2022"},{"issue":"8","key":"pone.0339336.ref038","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1001\/jamaoncol.2024.1891","article-title":"Endometrial Thickness as Diagnostic Triage for Endometrial Cancer Among Black Individuals","volume":"10","author":"KM Doll","year":"2024","journal-title":"JAMA Oncol"},{"issue":"6","key":"pone.0339336.ref039","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S1470-2045(23)00113-4","article-title":"Uterine cancer mortality and Black women: time to act","volume":"24","author":"EL Moss","year":"2023","journal-title":"Lancet Oncol"},{"key":"pone.0339336.ref040","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ygyno.2023.11.030","article-title":"Exploring the perspectives of underrepresented voices: Perceptions and experiences of uterine cancer for black African, Caribbean, black British, and mixed-black women in the UK to develop strategies for early symptom presentation","volume":"180","author":"N Darko","year":"2024","journal-title":"Gynecol Oncol"},{"key":"pone.0339336.ref041","doi-asserted-by":"crossref","unstructured":"Chitrakar A, Darko N, Millet N, Weekes S, Dhanota H, Lawrence A. You need to know: evaluation of a uterine cancer awareness campaign for Black and Asian ethnic minority women in North East London. BMJ Public Health 2025;3:e002475. doi: 10.1136\/bmjph-2024-002475","DOI":"10.1136\/bmjph-2024-002475"},{"key":"pone.0339336.ref042","doi-asserted-by":"crossref","first-page":"101690","DOI":"10.1016\/j.gore.2025.101690","article-title":"Seeing red.? Co-design of a culturally tailored uterine cancer awareness intervention for Asian and Black ethnic minority groups","volume":"58","author":"A Chitrakar","year":"2025","journal-title":"Gynecol Oncol Rep"},{"issue":"1","key":"pone.0339336.ref043","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41416-024-02674-y","article-title":"UK guidelines for the management of soft tissue sarcomas","volume":"132","author":"AJ Hayes","year":"2025","journal-title":"Br J Cancer"},{"issue":"9","key":"pone.0339336.ref044","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.ejso.2017.06.009","article-title":"Needle tract seeding following core biopsies in retroperitoneal sarcoma","volume":"43","author":"WJ Van Houdt","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"pone.0339336.ref045","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1038\/s41467-022-30496-0","article-title":"Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma","volume":"13","author":"MM Gounder","year":"2022","journal-title":"Nat Commun"},{"issue":"1125","key":"pone.0339336.ref046","doi-asserted-by":"crossref","first-page":"20201332","DOI":"10.1259\/bjr.20201332","article-title":"Differentiating uterine sarcoma from leiomyoma: BET1T2ER Check!","volume":"94","author":"J Smith","year":"2021","journal-title":"Br J Radiol"},{"issue":"1","key":"pone.0339336.ref047","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40644-019-0206-8","article-title":"Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI","volume":"19","author":"M Malek","year":"2019","journal-title":"Cancer Imaging"},{"issue":"2","key":"pone.0339336.ref048","doi-asserted-by":"crossref","DOI":"10.1016\/j.crad.2018.10.010","article-title":"A multiparametric MRI-based machine learning to distinguish between uterine sarcoma and benign leiomyoma: comparison with 18F-FDG PET\/CT","volume":"74","author":"M Nakagawa","year":"2019","journal-title":"Clin Radiol"},{"key":"pone.0339336.ref049","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejrad.2018.11.009","article-title":"A machine learning approach for distinguishing uterine sarcoma from leiomyomas based on perfusion weighted MRI parameters","volume":"110","author":"M Malek","year":"2019","journal-title":"Eur J Radiol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0339336","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T18:43:58Z","timestamp":1771353838000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0339336"}},"subtitle":[],"editor":[{"given":"Mohamed","family":"Gouda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":49,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0339336","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]}}}